Halozyme Therapeutics Aktie
57,42
EUR
+0,30
EUR
+0,53
%
67,30
USD
+0,32
USD
+0,48
%
Werbung
Halozyme Therapeutics Aktie Analyse
| 15.11.24 | Halozyme Therapeutics Neutral | JP Morgan Chase & Co. | |
| 27.09.12 | Halozyme Therapeutics neutral | UBS AG | |
| 12.08.08 | Halozyme Therapeutics hold | Brean Murray, Carret & Co., LLC |
Werbung
Werbung